Quarter
Charts

Viridian Therapeutics, Inc.\DE

VRDN

CIK 0001590750 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$132K
↑+83.3% +$60Kvs FY2024 (Q4)
Gross Profit
$132K
↑+83.3% +$60Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
66/100
  • Profitability
    0ROIC -41.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 12.65 (above 1.5 = solid)
  • Leverage
    98D/E 0.03 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.09x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +83.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -56.7% · trend +727.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$495K
investment in PP&E
Stock-based comp (TTM)
$44M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$899M
everything owned
Total liabilities
$177M
everything owed
Stockholders' equity
$722M
shareholder claim
Net debt
$-854M
Net cash position ($854M)

Recent performance · 51 quarters

Revenue↑+83.3% +$60K
$132K
Net Income↑+54.9% +$42M
$-35M
Free Cash Flow↓-110.5% -$126K
$-240K
Operating Margin↑+97013.1pts
-56.7%

Drill down

VRDN Sankey

See Viridian Therapeutics, Inc.\DE's revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

VRDN Charts

51 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

VRDN Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics